873-49-4 | Cyclopropylbenzene

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$10.00	$7.00
5g	97%	in stock	$22.00	$16.00
10g	97%	in stock	$42.00	$30.00
25g	97%	in stock	$90.00	$63.00
100g	97%	in stock	$330.00	$231.00
500g	97%	in stock	$1,494.00	$1,046.00

Description

• Catalog Number: AD91404
• Chemical Name: Cyclopropylbenzene
• CAS Number: 873-49-4
• Molecular Formula: C9H10
• Molecular Weight: 118.1757
• MDL Number: MFCD00001275
• SMILES: C1CC1c1ccccc1
• NSC Number: 3018

Computed Properties

• Complexity: 86.2
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 9
• Rotatable Bond Count: 1
• XLogP3: 3.3

Literature

• Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors.

  European journal of medicinal chemistry 20120901

• Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4-diones.

  Bioorganic & medicinal chemistry 20111015

• Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.

  Bioorganic & medicinal chemistry letters 20110801

• The design and application of target-focused compound libraries.

  Combinatorial chemistry & high throughput screening 20110701

• Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins.

  Archiv der Pharmazie 20110401

• Synthesis and anticancer activity evaluation of 2(4-alkoxyphenyl)cyclopropyl hydrazides and triazolo phthalazines.

  Bioorganic & medicinal chemistry 20100401

• Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.

  Cardiovascular therapeutics 20090101

• Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats.

  Anesthesia and analgesia 20080801

• Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor Xa.

  Bioorganic & medicinal chemistry letters 20080715

• Mass spectrometric studies on 4-aryl-1-cyclopropyl-1,2-dihydropyridinyl derivatives: an examination of a novel fragmentation pathway.

  Journal of mass spectrometry : JMS 20061201

• Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.

  Journal of medicinal chemistry 20060420

• (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

  Journal of medicinal chemistry 20050324

• Oxidation of alkylarenes by nitrate catalyzed by polyoxophosphomolybdates: synthetic applications and mechanistic insights.

  Journal of the American Chemical Society 20040526

• Thermal reactions of an overcrowded germacyclopropabenzene with group 6 metal hexacarbonyl complexes [M(CO)6](M = Cr, Mo, and W): a novel mode of CO insertion leading to the formation of cyclic germoxycarbene metal complexes.

  Chemical communications (Cambridge, England) 20040221

• Molecular structure and conformation of cyclopropylbenzene as determined by ab initio molecular orbital calculations, pulsed-jet fourier transform microwave spectroscopic, and gas-phase electron diffraction investigations.

  The Journal of organic chemistry 20010824

• In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

  Drug metabolism and disposition: the biological fate of chemicals 20010301